28688011000001103: Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\UK product\Virtual medicinal product\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\UK product\Virtual therapeutic moiety\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\UK product\Trade family\Viekirax\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing Hepatitis C virus protein NS5A inhibitor (product)\Product containing ombitasvir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing Hepatitis C virus NS3/4A protease inhibitor (product)\Product containing paritaprevir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing protease inhibitor\Product containing ritonavir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing ritonavir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing ritonavir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Medicinal product acting as antiretroviral agent (product)\Product containing ritonavir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing ombitasvir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiviral agent (product)\Product containing paritaprevir\Product containing ombitasvir and paritaprevir and ritonavir\Paritaprevir + Ritonavir + Ombitasvir\Generic Viekirax 12.5mg/75mg/50mg tablets\Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Feb 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

89553101000001116 Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

89553201000001111 Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator	EMA (European Medicines Agency) monitoring	false	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Is a	Generic Viekirax 12.5mg/75mg/50mg tablets	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	VMP prescribing status (attribute)	Never valid to prescribe as a VMP	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has specific active ingredient	Ritonavir	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has specific active ingredient	Paritaprevir	false	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has specific active ingredient	Ombitasvir	false	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Is a	Viekirax	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has active ingredient	Substance with antiviral mechanism of action	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has active ingredient	Ritonavir	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has specific active ingredient	Paritaprevir	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has specific active ingredient	Ombitasvir	true	Inferred relationship	Existential restriction modifier
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd) 56 tablet 4 x 14 tablets	Has AMP	True	Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
89553101000001116	Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
89553201000001111	Viekirax 12.5mg/75mg/50mg tablets (AbbVie Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module